Wuhan YZY Biopharma Co (HKSE:02496) PB Ratio: (As of Jul. 23, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Wuhan YZY Biopharma Co PB Ratio?

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. As of today (2026-07-23), Wuhan YZY Biopharma Co's share price is HK$3.69. Wuhan YZY Biopharma Co's Book Value per Share for the quarter that ended in Dec. 2025 was HK$-0.30. Hence, Wuhan YZY Biopharma Co's PB Ratio of today is .

The historical rank and industry rank for Wuhan YZY Biopharma Co's PB Ratio or its related term are showing as below:

During the past 5 years, Wuhan YZY Biopharma Co's highest PB Ratio was 46.90. The lowest was 25.06. And the median was 35.12.

HKSE:02496's PB Ratio is not ranked *
in the Biotechnology industry.
Industry Median: 2.82
* Ranked among companies with meaningful PB Ratio only.

During the past 12 months, Wuhan YZY Biopharma Co's average Book Value Per Share Growth Rate was -279.80% per year.

During the past 5 years, the highest 3-Year average Book Value Per Share Growth Rate of Wuhan YZY Biopharma Co was -43.00% per year. The lowest was -43.00% per year. And the median was -43.00% per year.

Back to Basics: PB Ratio

Wuhan YZY Biopharma Co  (HKSE:02496) PB Ratio Explanation

Unlike valuation ratios relative to the earning power such as PE Ratio, PE Ratio without NRI, PS Ratio, Price-to-Operating-Cash-Flow , or Price-to-Free-Cash-Flow, the PB Ratio measures the valuation of the stock relative to the underlying asset of the company.

The PB Ratio works the best for the businesses that earn most of their profit from their assets, e.g. banks and insurance companies.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The PB Ratio does not work well for these companies. Some companies even have negative equity, so the PB Ratio cannot be applied to them.

Wuhan YZY Biopharma Co PB Ratio Related Terms

Wuhan YZY Biopharma Co PB Ratio Historical Data

* Premium members only.

The historical data trend for Wuhan YZY Biopharma Co's PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Wuhan YZY Biopharma Co PB Ratio Chart

Wuhan YZY Biopharma Co Annual Data
Trend Dec21 Dec22 Dec23 Dec24 Dec25
PB Ratio
0.00 0.00 12.36 49.29 0.00

Wuhan YZY Biopharma Co Semi-Annual Data
Dec21 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
PB Ratio Get a 7-Day Free Trial 12.36 28.47 49.29 0.00 0.00

HKSE:02496 vs VRTX, REGN, ALNY: PB Ratio Comparison

For the Biotechnology subindustry, Wuhan YZY Biopharma Co's PB Ratio, along with its competitors' market caps and PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Wuhan YZY Biopharma Co PB Ratio vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Wuhan YZY Biopharma Co's PB Ratio distribution charts can be found below:

* The bar in red indicates where Wuhan YZY Biopharma Co's PB Ratio falls into.


Wuhan YZY Biopharma Co PB Ratio Calculation

The PB Ratio, or Price-to-Book ratio, or Price/Book, is a financial ratio used to compare a company's market price to its Book Value per Share. It is a ratio widely used to value stocks.

Wuhan YZY Biopharma Co's PB Ratio for today is calculated as follows:

PB Ratio=Share Price/Book Value per Share (Q: Dec. 2025)
=3.69/-0.302
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

PB Ratio=Market Cap /(Total Stockholders Equity-Preferred Stock)

A closely related ratio is called Price-to-Tangible-Book. The difference between Price-to-Tangible-Book and PB Ratio is that book value other than intangibles are used in the calculation.

Wuhan YZY Biopharma Co Business Description

Address No. 666 Gaoxin Road, Building C2-1, Optics Valley Bio-City, East Lake High Tech Development Zone, Hubei Province, Wuhan, CHN
Wuhan YZY Biopharma Co Ltd is a biotechnology company dedicated to developing bispecific antibody (BsAb)- based therapies. The Company has been forward-looking in deploying its presence in several therapeutic fields, including but not limited to tumor-associated complications, tumors, ophthalmology, and autoimmune diseases. The Company also proactively established several self-developed technology platforms, such as Y-BODY, Check-Body, and Nano-Ybody, promoting the development of more candidates to clinical stages with high efficiency.